A clear view before another major decision
A Founder Diagnostic shows you the company as it is today—not as the pitch deck describes it, not as the team hopes it will become and not as another consultant assumes it should work.
We examine the evidence, identify the real constraints and turn the findings into a practical 90-day operating plan.
They apply because too much is happening at once.
Every option sounds defensible. None feels certain.
At this stage, speed is not always the answer. A company can move quickly in the wrong direction.
The Diagnostic creates a pause long enough to understand what the company is actually telling you.
Launch price€690
For founders who have built the product but do not yet have a clear way to position, sell and grow it.
We examine the business model, customer, positioning, offer, pricing, go-to-market, sales, activation, retention and commercial metrics.
You leave with a clearer commercial direction and a prioritised 90-day growth roadmap.
Launch price€1,190
For founders whose business, product, growth and technical problems are already affecting one another.
Martin and Sebastian examine the company together and connect the findings into one integrated roadmap.
You leave with one complete view of the company and the correct sequence for the next 90 days.
Read-only repository access is required.
Launch price€790
For founders who need an independent view of the codebase, architecture, infrastructure, technical debt and development process.
You leave with a clear technical risk profile and a prioritised roadmap.
Read-only repository access is required.
Launch prices apply to the first three to five completed engagements and exclude VAT where applicable.
Every Diagnostic includes a structured Founder Scorecard, maturity and risk evaluation, evidence confidence, prioritised findings and a 90-day roadmap.
You receive a written report and a 60–90 minute final presentation. Approximately 14 days later, we meet again for a 30-minute follow-up to review questions and the first decisions.
More activity can hide a lack of direction.
Some findings will be confirmed by direct data and system evidence. Others will be strong indications supported by several signals. Some will remain hypotheses that need to be tested.
We make those distinctions visible.
A missing dashboard does not prove that performance is poor.
It also does not prove that performance is healthy.
A functioning application does not prove that the architecture is ready to scale.
A large user count does not prove the business model works.
A strong codebase does not prove the company is building the right product.
False certainty is expensive.
The correct next step may be:
Founder-led execution.
Giving the roadmap to your existing team.
Hiring a specific internal role.
Using another specialist.
A fractional leadership engagement.
A defined recovery project.
Delaying growth and stabilising the product first.
We do not decide the answer before completing the analysis.
That is the point.
No.
It is a paid, standalone engagement with defined deliverables. You can implement the findings without continuing with UNQRN Growth.
No.
The Diagnostic identifies what should be done. Implementation and production are scoped separately.
No.
We provide recommendations based on the available evidence. Results depend on execution, market conditions and other factors outside any advisor’s control.
After the kick-off is complete and all required information, data and system access have been verified.
Yes, for the Technology & Architecture Diagnostic and the Full Founder Diagnostic.
No.
The product must exist as a functioning MVP.
For most new clients, the Diagnostic is the required starting point. It creates a shared understanding of the priorities, evidence and responsibilities before an ongoing engagement begins.
Standard fixed prices apply to a qualified scope. Large, regulated or specialist systems require individual scoping and pricing.